weight loss retatrutide VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
The drug mimics a natural hormone called GLP-1 receptor agonists produced in the gut, reducing hunger and cravings and preventing overeating

Patients often describe a specific pattern of vanishing food cravings preceding a decrease in libido
)
Deficiencies in key nutrients can impair metabolic function in ways that contribute to stalls

You can also submit the website to your countrys consumer protection agency and the FDAs Health Fraud Program

Its only one study but its an interesting data point nonetheless

Lancet 392 , 15191529 (2018)